SEC EDGAR filings, ownership reports, and insider transactions for New Enterprise Associates 14, L.P..
Recent SEC filings for New Enterprise Associates 14, L.P. including SCHEDULE 13D/A, 144, SCHEDULE 13G/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 19 Aug 2025 | |||
| 144 | Open 144 document | View SEC filing for 144 | 15 Aug 2025 | |||
| 144 | Open 144 document | View SEC filing for 144 | 15 Aug 2025 | |||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | Open XBRL data | View SEC filing for SCHEDULE 13G/A | 14 Feb 2025 | |||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | Open XBRL data | View SEC filing for SCHEDULE 13D/A | 07 Jan 2025 | |||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. / TUYA, INC. -- 13G/A(#2) | 01 Nov 2024 | ||
| 144 | Open 144 document | View SEC filing for 144 | 17 Jul 2024 | |||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- SYNLOGIC, INC. 13D/A(#5) | 16 May 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- ZEROFOX HOLDINGS, INC. 13D/A(#1E) | 15 May 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 15 May 2024 | 13 May 2024 | 001-39722 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- NEXTNAV 13D/A(#1) | 10 May 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- CHAMPIONS ONCOLOGY 13D/A(#1) | 06 May 2024 | ||
| 144 | Open 144 document | View SEC filing for 144 | 19 Apr 2024 | |||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- ADAPTIMMUNE 13D/A(#2) | 02 Apr 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- SYNLOGIC, INC. 13D/A(#4) | 13 Oct 2023 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 06 Oct 2023 | 03 Oct 2023 | 001-37566 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- ADAPTIMMUNE 13D/A(#1) | 30 Mar 2023 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. / TUYA, INC. -- 13G/A(#1) | 03 Feb 2023 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#2E) | 09 Jan 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Jan 2023 | 03 Jan 2023 | 001-39112 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- OYSTER POINT PHARMA, INC. 13D/A(#1) | 21 Nov 2022 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. -- ZEROFOX HOLDINGS, INC. 13D | 12 Aug 2022 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Aug 2022 | 03 Aug 2022 | 001-39722 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA3E | 24 May 2022 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA2 | 25 Apr 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Apr 2022 | 05 Apr 2022 | 001-39247 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEW ENTERPRISE ASSOCIATES 14, L.P. / TUYA, INC. -- 13G | 15 Feb 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Jan 2022 | 25 Jan 2022 | 001-39214 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Jan 2022 | 21 Jan 2022 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jan 2022 | 18 Jan 2022 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Jan 2022 | 12 Jan 2022 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jan 2022 | 07 Jan 2022 | 001-39247 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- IMARA INC. 13DA1 | 10 Jan 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jan 2022 | 04 Jan 2022 | 001-39247 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- LUMOS PHARMA, INC. 13D/A1E | 05 Jan 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Jan 2022 | 30 Dec 2021 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Dec 2021 | 27 Dec 2021 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Dec 2021 | 09 Dec 2021 | 001-39247 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. -- NEXTNAV INC. 13D | 01 Dec 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- CASPER SLEEP INC. 13DA1 | 22 Nov 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. (TRACON) - SCHEDULE 13DA3E | 11 Mar 2021 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. / SURFACE ONCOLOGY, INC. -- 13GA2E | 12 Feb 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- MERSANA THERAPEUTICS. 13DA5 | 10 Dec 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- MERSANA THERAPEUTICS. 13DA4 | 19 Nov 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- MERSANA THERAPEUTICS. 13DA3 | 22 Sep 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Sep 2020 | 14 Sep 2020 | 001-38129 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 May 2020 | 20 May 2020 | 001-38459 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. -- MERSANA THERAPEUTICS. 13DA2 | 24 Apr 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Apr 2020 | 09 Apr 2020 | 001-38129 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Apr 2020 | 28 Aug 2019 | 001-38129 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEA 14 LP / LUMOS PHARMA - SCHEDULE 13D | 01 Apr 2020 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEA 14 - IMARA INC. -- SCHEDULE 13D | 20 Mar 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Mar 2020 | 16 Mar 2020 | 001-39247 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 11 Mar 2020 | 11 Mar 2020 | 001-39247 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Mar 2020 | 06 Mar 2020 | 001-11504 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. - CASPER SLEEP INC. 13D | 20 Feb 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - SURFACE ONCOLOGY, INC. -- SCHEDULE 13G/A (A | 13 Feb 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - MONGODB, INC. -- SCHEDULE 13G/A (AMEND. NO. | 13 Feb 2020 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEW ENTERPRISE ASSOCIATES 14, L.P. - GALERA THERAPEUTICS, INC. -- SCHEDULE 13G | 13 Feb 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - ELASTIC N.V. -- SCHEDULE 13G/A - AMEND. NO. | 13 Feb 2020 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2020 | 10 Feb 2020 | 001-39214 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 06 Feb 2020 | 06 Feb 2020 | 001-39214 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Nov 2019 | 12 Nov 2019 | 001-39114 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. - OYSTER POINT PHARMA, INC. 13D | 08 Nov 2019 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 06 Nov 2019 | 06 Nov 2019 | 001-39114 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Nov 2019 | 04 Nov 2019 | 001-39112 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 Oct 2019 | 30 Oct 2019 | 001-39112 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - MERSANA THERAPEUTICS 13D/A(#1) | 14 Mar 2019 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 05 Mar 2019 | 001-38129 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEW ENTERPRISE ASSOCIATES 14, L.P. - ELASTIC N.V. -- SCHEDULE 13G | 13 Feb 2019 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEW ENTERPRISE ASSOCIATES 14, L.P. - SURFACE ONCOLOGY, INC. -- SCHEDULE 13G | 13 Feb 2019 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEW ENTERPRISE ASSOCIATES, 14 L.P. / APPIAN CORPORATION - 13GA (#1) | 12 Feb 2019 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. / ADAPTIMMUNE THERAPEUTICS PLC -- SCHEDULE 13 | 17 Sep 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Sep 2018 | 07 Sep 2018 | 001-37368 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. / MULESOFT, INC. -- SCHEDULE 13D/A1 | 14 May 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 May 2018 | 01 May 2018 | 001-38031 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Apr 2018 | 23 Apr 2018 | 001-38459 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 18 Apr 2018 | 18 Apr 2018 | 001-38459 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. / TRACON PHARMACEUTICALS -- SCHEDULE 13D/A (# | 03 Apr 2018 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | NEW ENTERPRISE ASSOCIATES 14, L.P. / MULESOFT, INC. -- SCHEDULE 13D | 29 Mar 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Mar 2018 | 26 Mar 2018 | 001-37368 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Mar 2018 | 27 Mar 2018 | 001-36818 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Mar 2018 | 21 Mar 2018 | 001-37368 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Feb 2018 | 13 Feb 2018 | 001-38098 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEA 14, L.P. - MONGODB, INC. - SCHEDULE 13G | 12 Feb 2018 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - SYNLOGIC, INC. 13DA (#3) | 01 Feb 2018 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEA 14 / MULESOFT, INC. - 13G | 29 Jan 2018 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEA 14 / ADAPTIMMUNE THERAPEUTICS PLC - 13GA (AMEND. #2) | 29 Jan 2018 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEA 14 / APPIAN CORPORATION - 13G | 29 Jan 2018 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Jan 2018 | 26 Jan 2018 | 001-37566 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 09 Jan 2018 | 01 Jan 2018 | 001-37569 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Nov 2017 | 27 Nov 2017 | 001-38098 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Nov 2017 | 20 Nov 2017 | 001-38098 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | NEW ENTERPRISE ASSOCIATES 14, L.P. - SYNLOGIC, INC. 13DA (#2) | 07 Sep 2017 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Aug 2017 | 28 Aug 2017 | 001-37566 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | MERSANA THERAPEUTICS, INC. - SCHEDULE 13D | 11 Jul 2017 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jul 2017 | 03 Jul 2017 | 001-38129 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 27 Jun 2017 | 27 Jun 2017 | 001-38129 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 May 2017 | 31 May 2017 | 001-38098 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 May 2017 | 24 May 2017 | 001-38098 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | MIRNA THERAPEUTICS, INC. - SCHEDULE 13D/A (AMEND. NO. 1) | 16 May 2017 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Mar 2017 | 27 Mar 2017 | 001-37368 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Mar 2017 | 22 Mar 2017 | 001-38031 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 16 Mar 2017 | 16 Mar 2017 | 001-38031 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEA 14 / ADAPTIMMUNE THERAPEUTICS PLC - 13GA (AMEND. #1) | 14 Feb 2017 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEA 14 / CERECOR INC - SCHEDULE 13G (AMEND. 1) | 06 Feb 2017 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13DA (#1) | 08 Dec 2016 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Nov 2016 | 29 Nov 2016 | 001-36818 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13DA (AMEND. #2) | 21 Nov 2016 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13DA (AMEND. #1) | 13 Sep 2016 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Aug 2016 | 29 Jul 2016 | 001-32715 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ADAPTIMMUNE THERAPEUTICS PLC | 10 Feb 2016 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | NEVRO CORP.-AMENDMENT #1 | 01 Feb 2016 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | CERECOR INC. | 01 Feb 2016 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 04 Jan 2016 | 01 Jan 2016 | 001-37368 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Oct 2015 | 20 Oct 2015 | 001-37590 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 14 Oct 2015 | 14 Oct 2015 | 001-37590 |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | MIRNA THERAPEUTICS, INC. | 14 Oct 2015 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Oct 2015 | 05 Oct 2015 | 001-37566 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 30 Sep 2015 | 30 Sep 2015 | 001-37566 |
| 3 | Open 3 document | View SEC filing for 3 | 24 Mar 2015 | 11 Mar 2015 | 000-17263 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | CHAMPIONS ONCOLOGY, INC. | 24 Mar 2015 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | TRACON PHARMACEUTICALS | 11 Feb 2015 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | NEVRO CORP. | 09 Feb 2015 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Feb 2015 | 04 Feb 2015 | 001-36818 | |
| 3 | Open 3 document | View SEC filing for 3 | 29 Jan 2015 | 29 Jan 2015 | 001-36818 | |
| 4 | Open 4 document | View SEC filing for 4 | 29 Dec 2014 | 23 Dec 2013 | 001-32715 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | LOXO ONCOLOGY | 12 Aug 2014 | ||
| 4 | Open 4 document | View SEC filing for 4 | 06 Aug 2014 | 06 Aug 2013 | 001-36562 | |
| 3 | Open 3 document | View SEC filing for 3 | 31 Jul 2014 | 31 Jul 2014 | 001-36562 | |
| 3 | Open 3 document | View SEC filing for 3 | 23 May 2013 | 17 May 2013 | 001-32715 | |
| D/A | Open D/A document | View SEC filing for D/A | 09 May 2012 | 021-175533 | ||
| D | Open D document | View SEC filing for D | 26 Mar 2012 | 021-175533 |
New Enterprise Associates 14, L.P. files with the SEC under CIK 0001544328. This page aggregates EDGAR filings and related ownership activity.